INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 146 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $713 | +8.5% | 53,116 | -0.0% | 0.30% | +2.4% |
Q4 2022 | $657 | -99.9% | 53,132 | -7.4% | 0.29% | -22.1% |
Q3 2022 | $801,000 | +9.3% | 57,396 | -0.1% | 0.38% | +26.7% |
Q2 2022 | $733,000 | -27.6% | 57,482 | -7.6% | 0.30% | -20.0% |
Q1 2022 | $1,012,000 | +4.3% | 62,185 | +4.4% | 0.37% | +6.6% |
Q4 2021 | $970,000 | – | 59,556 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |